Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination
Chinmay R Surve, Camille L Duran, Xianjun Ye, et al.
Science Translational Medicine
|
July 7, 2017
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S Karagiannis, Jessica M Pastoriza, Yarong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
Martin Schuler, Lisa Zimmer, Kevin B Kim, et al.
Molecular Cancer Therapeutics
|
August 26, 2017
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2<sup>Hi</sup> Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
Allison S Harney, George S Karagiannis, Jeanine Pignatelli, et al.
NPJ Breast Cancer
|
September 2, 2022
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy
George S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez, et al.
Cancer Discovery
|
October 27, 2018
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
Xia Liu, Rokana Taftaf, Madoka Kawaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
Cancer Discovery
|
June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy
Alexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer
Dimitra P Anastasiadou, Nicole Couturier, Sakshi Goel, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Biorxiv : the Preprint Server for Biology
|
January 23, 2024
Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination
Chinmay R Surve, Camille L Duran, Xianjun Ye, et al.
Science Translational Medicine
|
July 7, 2017
Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
George S Karagiannis, Jessica M Pastoriza, Yarong Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 16, 2022
Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma
Martin Schuler, Lisa Zimmer, Kevin B Kim, et al.
Molecular Cancer Therapeutics
|
August 26, 2017
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2<sup>Hi</sup> Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
Allison S Harney, George S Karagiannis, Jeanine Pignatelli, et al.
NPJ Breast Cancer
|
September 2, 2022
Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy
George S Karagiannis, Anthony Bianchi, Luis Rivera Sanchez, et al.
Cancer Discovery
|
October 27, 2018
Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models
Xia Liu, Rokana Taftaf, Madoka Kawaguchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2025
Longitudinal Genomic Analysis to Fine-tune Targeted Therapy: Results of the Phase II LOGIC 2 Trial in Patients with BRAFV600-Mutant Metastatic Melanoma
Reinhard Dummer, Shahneen Sandhu, Wilson H Miller, et al.
Cancer Discovery
|
June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy
Alexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Biorxiv : the Preprint Server for Biology
|
October 28, 2024
Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer
Dimitra P Anastasiadou, Nicole Couturier, Sakshi Goel, et al.
Page
of 4